---
title: 'Lysine restricted diet for pyridoxine-dependent epilepsy: first evidence and
  future trials'
authors:
- Clara D. M. van Karnebeek
- Hans Hartmann
- Sravan Jaggumantri
- Levinus A. Bok
- Barb Cheng
- Mary Connolly
- Curtis R. Coughlin
- Anibh M. Das
- Sidney M. Gospe
- Cornelis Jakobs
- Johanna H. van der Lee
- Saadet Mercimek-Mahmutoglu
- Uta Meyer
- Eduard Struys
- Graham Sinclair
- Johan Van Hove
- Jean-Paul Collet
- Barbara R. Plecko
- Sylvia Stockler
date: '2012-11-01'
publishDate: '2025-12-29T01:49:05.550361Z'
publication_types:
- article-journal
publication: '*Mol Genet Metab*'
doi: 10.1016/j.ymgme.2012.09.006
abstract: 'OBJECTIVE: To evaluate the efficacy and safety of dietary lysine restriction
  as an adjunct to pyridoxine therapy on biochemical parameters, seizure control,
  and developmental/cognitive outcomes in children with pyridoxine-dependent epilepsy
  (PDE) caused by antiquitin (ATQ) deficiency. METHODS: In this observational study,
  seven children with confirmed ATQ deficiency were started on dietary lysine restriction
  with regular nutritional monitoring. Biochemical outcomes were evaluated using pipecolic
  acid and Î±-aminoadipic semialdehyde (AASA) levels in body fluids; developmental/cognitive
  outcomes were evaluated using age-appropriate tests and parental observations. RESULTS:
  Lysine restriction was well tolerated with good compliance; no adverse events were
  reported. Reduction in biomarker levels (measurement of the last value before and
  first value after initiation of dietary lysine restriction) ranged from 20 to 67%
  for plasma pipecolic acid, 13 to 72% for urinary AASA, 45% for plasma AASA and 42%
  for plasma P6C. For the 1 patient in whom data were available and who showed clinical
  deterioration upon interruption of diet, cerebrospinal fluid levels decreased by
  87.2% for pipecolic acid and 81.7% for AASA. Improvement in age-appropriate skills
  was observed in 4 out of 5 patients showing pre-diet delays, and seizure control
  was maintained or improved in 6 out 7 children. CONCLUSIONS: This observational
  study provides Level 4 evidence that lysine restriction is well tolerated with significant
  decrease of potentially neurotoxic biomarkers in different body compartments, and
  with the potential to improve developmental outcomes in children with PDE caused
  by ATQ deficiency. To generate a strong level of evidence before this potentially
  burdensome dietary therapy becomes the mainstay treatment, we have established:
  an international PDE consortium to conduct future studies with an all-inclusive
  integrated study design; a website containing up-to-date information on PDE; a methodological
  toolbox; and an online registry to facilitate the participation of interested physicians,
  scientists, and families in PDE research.'
tags:
- 2-Aminoadipic Acid
- Aldehyde Dehydrogenase
- Child
- Child
- Preschool
- Cognition
- Diet
- Epilepsy
- Female
- Humans
- Infant
- Longitudinal Studies
- Lysine
- Male
- Pipecolic Acids
- Pyridoxine
---
